U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07398469) titled 'A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting Zuranolone' on Feb. 04.
Brief Summary: In this study, researchers will learn how postpartum depression symptoms may change after people first start taking zuranolone. This is a drug available for doctors to prescribe for people with postpartum depression, also known as PPD. After giving birth, people with PPD can suffer from symptoms like tiredness, sadness, and a loss of interest in their daily activities.
This is known as an "observational" study, which collects health information about study participants without changing their medi...